Page last updated: 2024-09-04

birb 796 and bibw 2992

birb 796 has been researched along with bibw 2992 in 1 studies

Compound Research Comparison

Studies
(birb 796)
Trials
(birb 796)
Recent Studies (post-2010)
(birb 796)
Studies
(bibw 2992)
Trials
(bibw 2992)
Recent Studies (post-2010) (bibw 2992)
1375801,0441471,007

Protein Interaction Comparison

ProteinTaxonomybirb 796 (IC50)bibw 2992 (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.0361
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.0168
Cytochrome P450 1A2Homo sapiens (human)0.037
Cytochrome P450 2E1Homo sapiens (human)0.014
Cytochrome P450 2C8Homo sapiens (human)0.037
Receptor tyrosine-protein kinase erbB-3Homo sapiens (human)0.0007
Cytochrome P450 2C19Homo sapiens (human)0.037
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.0016
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)0.0024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1

Other Studies

1 other study(ies) available for birb 796 and bibw 2992

ArticleYear
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011